Horst Böshagen

The chemistry of the 1-deoxynojirimycin system. Synthesis of 2-acetamido-1,2-dideoxynojirimycin from 1-deoxynojirimycin

Horst Böshagen, Fred-Robert Heiker, A. Matthias Schüller · Carbohydrate Research · 1987 · 44 citations

Biosynthesis, Bioorganic Chemistry, Engineering +9

A new structural analogue antagonist of peptido-leukotrienes. The discovery of bay x7195

Trevor S. Abram, Horst Böshagen, Janet Butler et al. · Bioorganic & Medicinal Chemistry Letters · 1993 · 22 citations

Molecular Pharmacology, Bay X7195, Biochemistry +5

Reaction of 1‐α‐Cyano‐1‐deoxynojirimycin with Grignard Compounds—Complete Exchange of the CN— Group

Horst Böshagen, Walter Geiger, Bodo Junge · Angewandte Chemie International Edition in English · 1981 · 22 citations

Medicinal Chemistry, 1-Deoxynojirimycin Derivatives, Bioorganic Chemistry +15

Synthesis and absolute configuration of the new thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-carbazolepropan oic acid and comparison with its enantiomer.

Ulrich Rosentreter, Horst Böshagen, F Seuter et al. · PubMed · 1989 · 21 citations

Bioorganic Chemistry, Organic Chemistry, Pharmacotherapy +17

Inhibition of platelet aggregation in vitro and ex vivo by the new thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9- carbazolepropanoic acid.

F Seuter, Elisabeth Perzborn, Ulrich Rosentreter et al. · PubMed · 1989 · 17 citations

Pharmacotherapy, Platelet Aggregation, Thrombosis +17